跳至主要内容
临床试验/ACTRN12623000844640
ACTRN12623000844640进行中(未招募)Unknown

Australian multicentre, prospective observational cohort study to evaluate the real-world efficacy of ustekinumab in patients with moderate to severe Crohn's disease: AURORA study

Mater Research Institute0 个研究点目标入组 197 人开始时间: 2023年8月7日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
197

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Participants must be men and women aged between 18 and 80 at the time of informed consent with moderately to severely active Crohn’s disease of at least 3 months’ duration since diagnosis who are eligible for ustekinumab treatment through the Australian Pharmaceutical Benefit Scheme.

排除标准

  • Unable to provide informed consent

研究者

相似试验